Below are the most recent publications written about "Palladium" by people in Profiles.
-
Xie S, Wang Z, Tan W, Zhu Y, Collier S, Ma L, Ehrlich SN, Xu P, Yan Y, Xu T, Deng J, Liu F. Highly Active and Stable Palladium Catalysts on Novel Ceria-Alumina Supports for Efficient Oxidation of Carbon Monoxide and Hydrocarbons. Environ Sci Technol. 2021 06 01; 55(11):7624-7633.
-
Sarkar A, Donavanik V, Zhang I, Chen H, Koprowski C, Hanlon A, Mourtada F, Strasser J, Raben A. Prostate implant dosimetric outcomes and migration patterns between bio-absorbable coated and uncoated brachytherapy seeds. Brachytherapy. 2013 Jul-Aug; 12(4):356-61.
-
Chiu-Tsao ST, Astrahan MA, Finger PT, Followill DS, Meigooni AS, Melhus CS, Mourtada F, Napolitano ME, Nath R, Rivard MJ, Rogers DW, Thomson RM. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS. Med Phys. 2012 Oct; 39(10):6161-84.
-
McAtee JR, Martin SE, Ahneman DT, Johnson KA, Watson DA. Preparation of allyl and vinyl silanes by the palladium-catalyzed silylation of terminal olefins: a silyl-Heck reaction. Angew Chem Int Ed Engl. 2012 Apr 10; 51(15):3663-7.
-
Thomson RM, Furutani KM, Pulido JS, Stafford SL, Rogers DW. Modified COMS plaques for 125I and 103Pd iris melanoma brachytherapy. Int J Radiat Oncol Biol Phys. 2010 Nov 15; 78(4):1261-9.
-
Hurwitz MD, Halabi S, Ou SS, McGinnis LS, Keuttel MR, Dibiase SJ, Small EJ. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809. Int J Radiat Oncol Biol Phys. 2008 Nov 1; 72(3):814-9.
-
Ho AY, Burri RJ, Jennings GT, Stone NN, Cesaretti JA, Stock RG. Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancer. Brachytherapy. 2007 Jan-Mar; 6(1):38-43.
-
Macmillan D, Anderson DW. Rapid synthesis of acyl transfer auxiliaries for cysteine-free native glycopeptide ligation. Org Lett. 2004 Dec 9; 6(25):4659-62.
-
Aboelella NW, York JT, Reynolds AM, Fujita K, Kinsinger CR, Cramer CJ, Riordan CG, Tolman WB. Mixed metal bis(mu-oxo) complexes with [CuM(mu-O)2]n+(M = Ni(III) or Pd(II)) cores. Chem Commun (Camb). 2004 Aug 7; (15):1716-7.
-
Chen CT, Waterman FM, Valicenti RK, Gomella LG, Strup SE, Dicker AP. Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy. Int J Cancer. 2001; 96 Suppl:83-8.